Part I. History<br><br>1. A Brief History of Blood Transfusion<br><br>Part II. Blood Banking<br><br>A. Immunohematology<br><br>i. Basic Principles<br><br>2. Principles of the Immune System Central to Transfusion Medicine<br>3. Principles of the Complement System Central to Transfusion Medicine<br>4. Principles of Red Blood Cell Allo- and Autoantibody Formation and Function<br><br>ii. Red Blood Cell, Platelet and Leukocyte Antigens and Antibodies<br><br>5. Membrane Blood Group Antigens and Antibodies<br>6. ABO and Related Antigens and Antibodies<br>7. Rh, Kell, Duffy, and Kidd Antigens and Antibodies<br>8. Other Blood Group Antigens and Antibodies<br>9. Human Platelet Antigens and Antibodies<br>10. HLA and Granulocyte Antigens and Antibodies<br><br>B. Blood Donation, Manufacturing, Testing and Storage<br><br>11. Blood Donation and Collection<br>12. Blood Manufacturing: Component Preparation, Storage and Transportation<br>13. Red Blood Cell Metabolism During Storage: Basic Principles and Practical Aspects<br>14. Infectious Disease Testing: Basic Principles and Practical Aspects<br><br>C. Regulatory, Quality and Legal Principles<br><br>15. Regulatory Principles and Issues Central to Blood Banking and Transfusion Medicine<br>16. Quality Assurance, Control and Improvement and Accreditation<br>17. Legal Principles and Issues Central to Transfusion Medicine<br><br>D. Specific Blood Components<br><br>18. Packed Red Blood Cell and Related Products<br>19. Fresh Frozen Plasma and Related Products<br>20. Cryoprecipitate and Related Products<br>21. Albumin<br>22. IVIg and Derivatives<br>23. Platelets and Related Products<br>24. Granulocytes<br>25. Coagulation Factor Preparations<br><br>E. Special Processes and Products<br><br>26. Leukocyte Reduced Products<br>27. Virus Safe Products: Pathogen Reduction and Inactivation<br>28. Irradiated Products<br>29. Washed and/or Volume Reduced Blood Components<br>30. Blood Management: Conservation, Salvage and Alternatives to Allogeneic Transfusion<br>31. Blood Substitutes: Basic Principles and Pracitcal Aspects<br><br>III. Transfusion Medicine<br><br>A. Transfusion in Specific Clinical Settings<br><br>32. Red Blood Cell Transfusion: Surgical and Traumatic Blood Loss and Anemia<br>33. Post-Transfusion Red Blood Cell and Platelet Survical and Kinetics: Basic Principles and Practical Aspects<br>34. Transfusion of the Patient with Congenital Coagulation Defects<br>35. Transfusion of the Patient with Acquired Coagulation Defects<br>36. Obstetric and Intrauterine Transfusion<br>37. Transfusion of the Neonates and Pediatric Patients<br>38. Transfusion of the Hemoglobinopathy Patient<br>39. Transfusion to Bone Marrow or Solid Organ Transplant Recipients<br>40. Transfusion of the Platelet Refractory Patient<br>41. Transfusion of the Patient with an Autoimmune Hemolytic Anemia<br>42. Transfusion in Economically-Restricted Countries and Developing Countries<br><br>B. Complications of Transfusion<br><br>i. Infectious Complications<br><br>43. Hepatitis A, B, and Non-A, Non-B, Non-C Viruses<br>44. Hepatitis C<br>45. HIV, HTLV, and Other Retroviruses<br>46. Human Herpesvirus Infections<br>47. Bacterial Infections: Bacterial Contamination, Testing and Post Transfusion Complications<br>48. Other Viral, Bacterial and Prion-Based Infectious Complications<br><br>ii. Non-Infectious Complications<br><br>49. Acute and Delayed Hemolytic Transfusion Reactions<br>50. Febrile, Allergic, and Other Noninfectious Transfusion Reactions<br>51. Transfusion-Related Acute Lung Injury<br>52. Transfusion-Related Immunomodulation<br>53. Post-Transfusion Engraftment Syndromes: Microchimerism and TA-GvHD<br><br>C. Therapeutic Apheresis<br><br>54. Therapeutic Apheresis: Basic Principles and Practical Aspects<br>55. Therapeutic Plasma Exchange<br>56. Therapeutic Cytapheresis<br><br>D. Cellular Therapies and Tissue Banking<br><br>57. The Role of Transfusion Medicine in Cellular Therapies <br>58. Bone Marrow and Peripheral Blood Stem Cells: Collection, Processing and Transfusion<br>59. Umbilical Cord Blood Stem Cells: Collection, Processing and Transfusion<br>60. Mononuclear Cell-Based Preparations<br>61. Tissue Banking in the Hospital Setting